A Prospective, Randomized, Subject and Vision-assessor Masked, Multicenter Study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, and Mixed Clareon PanOptix Pro/Vivity Intraocular Lens Implantation in Cataract Subjects
Part of paid clinical trials in Plymouth Meeting, Pennsylvania.
- Sponsor
- Berkeley Eye Center
- Study ID
- NCT06922084
- Phase
- PHASE4
- Status
- Recruiting
Conditions
- Cataract
Eligibility Criteria
- Sex
- ALL
- Age
- 40 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Clareon PanOptix — DEVICEBilateral Clareon PanOptix IOL implantation
- Clareon PanOptix PRO — DRUGBilateral Clareon PanOptix PRO IOL implantation
- Mix-and-Match PanOptix/Vivity — DRUGClareon PanOptix Pro in the non-dominant eye and Clareon Vivity in the dominant eye
Study Details
Prospective, randomized, multicenter, multi-arm, subject and vision-assessor-masked, two stage study with Stage 1 as a three-arm initial enrollment period, followed by Stage 2 as a head-to-head study refined based on the Stage 1 data.
Key Dates
- Start date
- Mar 17, 2025
- Status verified
- Apr 2025
- Primary completion
- Apr 30, 2026
- Completion
- Apr 30, 2026
Study Design
- Enrollment
- 320 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Bilateral Clareon PanOptix IOL implantation
- Experimental: Bilateral Clareon PanOptix Pro IOL implantation
- Experimental: Clareon PanOptix Pro in the non-dominant eye and Clareon Vivity in the dominant eye
Primary Outcome Measure
Binocular photopic CDVA (corrected distance visual acuity) [ Time Frame: 3 months postoperatively ]
Central Contacts
- Tetiana Huff713-620-7640
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Shafer Vision Institute | Plymouth Meeting | Pennsylvania | 19462 | Ailinn Dunn Brian Shafer (PRINCIPAL_INVESTIGATOR) |
| Berkeley Eye Center | Houston | Texas | 77027 | Morgan Micheletti, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Plymouth Meeting, PA
Related Studies
- IC-8 Apthera IOL New Enrollment Post Approval StudyRecruiting · Bausch & Lomb Incorporated · Dothan, Alabama
- A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)PHASE3 · Recruiting · Melt Pharmaceuticals · Chico, California
- Evaluation of a Monofocal Intraocular LensPHASE4 · Recruiting · Carl Zeiss Meditec AG · Indianapolis, Indiana
- Visual Outcomes in Patients Contralaterally Implanted With PanOptix Pro and Clareon Vivity Compared to Bilateral Implantation of PanOptix ProEnrolling By Invitation · Brian Shafer · Baltimore, Maryland